Search Results 491-500 of 19981 for endometrial cancer

1. A Study To Evaluate AZD1775 In Women With Recurrent Or Persistent Uterine Serous Carcinoma Or Uterine Carcinosarcoma - Mayo Clinic

   The purpose of this study is to evaluate an investigational drug as a possible treatment for uterine cancer, AZD1775. Participation eligibility. Participant ...

2. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   Prostate cancer, Breast cancer, Gynecologic cancer ... Endometrial biopsy, Abdominal surgery, Diagnostic ... tumor surgery, Pelvic tumor surgery, B...one ...

3. Race and Insurance Status Factor into Cancer Surgery for Women - Mayo Clinic News Network

   However, for patients with non-metastatic endometrial cancer, this is not the case. Although clear evidence and national guidelines direct the use of ...

4. Adnexal tumors and masses - Doctors and departments - Mayo Clinic

   Gynecologic Cancers Discussions. Helen, Volunteer Mentor · What were your first signs of endometrial cancer? 18 Replies Wed, Apr 16, 2025.

5. Breast cancer - Doctors and departments - Mayo Clinic

   Breast cancer, Cervical cancer, Ovarian cancer, Peritoneal cancer, Male breast cancer, Endometrial cancer, BRCA gene mu...tation. Show more areas of focus ...

6. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   D. Radiation Oncology Medical Physicist. Rochester, MN. Areas of focus: Prostate cancer, Breast cancer, Gynecologic cancer ... Endometrial biopsy, Abdominal ...

7. Lynch syndrome - Diagnosis and treatment - Mayo Clinic

   ... cancer or endometrial cancer. Other cancers caused by Lynch syndrome ... Endometrial cancer is cancer that starts in the inside lining of the uterus.

8. Vulvar cancer - Doctors and departments - Mayo Clinic

   What Kind of Radiation Did You Get for Your Gynecological Cancer? 108 Replies Sun, May 04, 2025. meandmsjones · Complex endometrial hyperplasia with atypia.

9. Clinical trials - Oncology (Medical)

   ... endometrial cancer. Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of ...

10. DESTINY-Endometrial01: A Phase III Study Of Trastuzumab Deruxtecan Plus Rilvegostomig Or Pembrolizumab As First-Line Treatment Of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer - Mayo Clinic

    ... Endometrial Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.